Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varadan Sevilimedu

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
JAMA Surgery|May 6, 2026
Sentinel Lymph Node Biopsy for Patients With cN1 HR+/HER2- Breast Cancer and Palpable Adenopathy: A Nonrandomized Clinical TrialAnita Mamtani, Melissa Pilewskie, Niamey Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO StudyGiacomo Montagna, Alison Laws, Massimo Ferrucci, et al.
The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
JAMA Surgery|May 6, 2026
Sentinel Lymph Node Biopsy for Patients With cN1 HR+/HER2- Breast Cancer and Palpable Adenopathy: A Nonrandomized Clinical TrialAnita Mamtani, Melissa Pilewskie, Niamey Wilson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2024
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO StudyGiacomo Montagna, Alison Laws, Massimo Ferrucci, et al.
The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.
JAMA Oncology|April 25, 2024
Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant ChemotherapyGiacomo Montagna, Mary M Mrdutt, Susie X Sun, et al.
Pageof 16